NeurosciencebioRxivPreprint
An engineered nanobody inhibitor for molecular-to-circuit control of opioid receptor function
Zoé Valbret, Paul J. Lamothe‐Molina, Sofia Papadogkonaki…·Miriam Stoeber
This paper develops an engineered nanobody inhibitor to control opioid receptor function with subcellular precision and demonstrates its effectiveness in vivo.
3 citations